Intra-Cellular Therapies Overview
Intra-Cellular Therapies Target Price
Analysts' 12-month price predictions for ITCI.
Share Price
$65
Average Target Price
$98.60
51.7% upside
51.7% upside5 analysts in the last 4 months
High: $107 | Low: $82
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-07 | RBC CapitalBrian Abrahams | $96 | 47.7% upside |  |
| 2024-05-07 | JefferiesAndrew Tsai | $105 | 61.5% upside | |
| 2024-04-23 | Canaccord GenuitySumant Kulkarni | $107 | 64.6% upside | |
| 2024-04-17 | Robert W. BairdJoel Beatty | $103 | 58.5% upside | |
| 2024-04-05 | NeedhamAmi Fadia | $82 | 26.2% upside | |
| 2022-06-13 | UBSAshwani Verma | $75 | 15.4% upside | |
| 2022-04-22 | Piper Sandler | $59 |  9.2% downside | |
| 2022-04-21 | Leerink Partners | $70 | 7.7% upside | |
| 2022-02-17 | Goldman SachsCorinne Jenkins | $64 | 1.5% downside | |